[[abstract]]©2003 Elsevier - The mechanism of poly (N-isopropylacrylamide) (PNIPAAm)-assisted protein folding was investigated. An optimal concentration equivalent to a molar ratio of polymer to carbonic anhydrase B (CAB) of ca. 2 was observed, in which the refolding yield was improved by 28%. At concentration above the critical level, PNIPAAm promotes protein precipitation leading to lower refolding yields, which is more significant when high molecular weight polymers are used. Results of fluorescence analysis and equilibrium studies indicate that PNIPAAm enhances protein refolding by the formation of complexes with aggregation-prone folding intermediates via hydrophobic interactions, as PEG. Results of stepwise dilution experiments indica...
The power and elegance of protein–polymer conjugates has solved many vexing problems for society. Ra...
A prospective technology for reversible enzyme complexation accompanied with its inactivation and pr...
Protein aggregation limits the development of protein-based drugs, and leads to neurological disorde...
Obtaining correctly folded proteins from inclusion bodies of recombinant proteins expressed in bacte...
Antibodies constitute the fastest growing class of human biopharmaceuticals. The development of thes...
Alginate, a calcium-sensitive polymer, could carry out simultaneous purification and refolding of 8 ...
Stabilization of the enzymes under stress conditions is of special interest for modern biochemistry,...
The attachment of inert polymers, such as polyethylene glycol, to proteins has driven the emergence ...
Abstract Large-scale expression of biopharmaceutical proteins in cellular hosts results in productio...
The protein-folding mechanism remains a major puzzle in life science. Purified soluble activation-in...
<p>Proteins and protein-based materials are used for a wide range of therapeutic, diagnostic, and bi...
Selective unfolding of native proteins may occur on the hydrophobic surface of nanoparticles, due to...
Large-scale expression of biopharmaceutical proteins in cellular hosts results in production of larg...
The formulation of novel therapeutic proteins is a challenging task which aims at finding formulatio...
A strategy called macro-(affinity ligand) facilitated three-phase partitioning (MLFTPP) is described...
The power and elegance of protein–polymer conjugates has solved many vexing problems for society. Ra...
A prospective technology for reversible enzyme complexation accompanied with its inactivation and pr...
Protein aggregation limits the development of protein-based drugs, and leads to neurological disorde...
Obtaining correctly folded proteins from inclusion bodies of recombinant proteins expressed in bacte...
Antibodies constitute the fastest growing class of human biopharmaceuticals. The development of thes...
Alginate, a calcium-sensitive polymer, could carry out simultaneous purification and refolding of 8 ...
Stabilization of the enzymes under stress conditions is of special interest for modern biochemistry,...
The attachment of inert polymers, such as polyethylene glycol, to proteins has driven the emergence ...
Abstract Large-scale expression of biopharmaceutical proteins in cellular hosts results in productio...
The protein-folding mechanism remains a major puzzle in life science. Purified soluble activation-in...
<p>Proteins and protein-based materials are used for a wide range of therapeutic, diagnostic, and bi...
Selective unfolding of native proteins may occur on the hydrophobic surface of nanoparticles, due to...
Large-scale expression of biopharmaceutical proteins in cellular hosts results in production of larg...
The formulation of novel therapeutic proteins is a challenging task which aims at finding formulatio...
A strategy called macro-(affinity ligand) facilitated three-phase partitioning (MLFTPP) is described...
The power and elegance of protein–polymer conjugates has solved many vexing problems for society. Ra...
A prospective technology for reversible enzyme complexation accompanied with its inactivation and pr...
Protein aggregation limits the development of protein-based drugs, and leads to neurological disorde...